M. Guaraldi
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
-
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 17
- Lung Cancer Research Studies 8
- Cancer Treatment and Pharmacology 6
- Cancer Diagnosis and Treatment 3
-
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Andrea Martoni (17 shared papers)F Pannuti (17 shared papers)Barbara Melotti (5 shared papers)H. Koussis (5 shared papers)Adriano Paccagnella (5 shared papers)Andrea Bonetti (5 shared papers)Maria Grazia Ghi (4 shared papers)E Piana (6 shared papers)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)Journal of Chemotherapy (3 papers)European Journal of Cancer (2 papers)Lung Cancer (2 papers)
- Partner nations
- Italy
In The Last Decade
M. Guaraldi
26 papers receiving 490 citations
Peers
Comparison fields: 5 of 53
- Otorhinolaryngology 195
- Oncology 190
- Pulmonary and Respiratory Medicine 187
- Surgery 104
- Cancer Research 18
Countries citing papers authored by M. Guaraldi
This map shows the geographic impact of M. Guaraldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guaraldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guaraldi more than expected).
Fields of papers citing papers by M. Guaraldi
This network shows the impact of papers produced by M. Guaraldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guaraldi. The network helps show where M. Guaraldi may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Guaraldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 129 | |
| 2 | 2004 | 61 | |
| 3 | 2014 | 48 | |
| 4 | 2001 | 33 | |
| 5 | 1992 | 30 | |
| 6 | 1998 | 26 | |
| 7 | 1991 | 26 | |
| 8 | 2001 | 23 | |
| 9 | 2013 | 20 | |
| 10 | 1996 | 17 | |
| 11 | 1990 | 16 | |
| 12 | 1992 | 14 | |
| 13 | 2012 | 11 | |
| 14 | Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer. | 1992 | 10 |
| 15 | 2009 | 8 | |
| 16 | Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis. | 1998 | 8 |
| 17 | Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer. | 2006 | 7 |
| 18 | 1991 | 5 | |
| 19 | 1999 | 5 | |
| 20 | 2009 | 4 |
About M. Guaraldi
M. Guaraldi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Surgery and Molecular Biology, having authored 27 papers that have together received 516 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (8 papers), Head and Neck Cancer Studies (6 papers), Cancer Treatment and Pharmacology (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cancer Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers) and Nausea and vomiting management (2 papers). The work is most often cited by research in Otorhinolaryngology (195 citations), Oncology (190 citations), Pulmonary and Respiratory Medicine (187 citations), Surgery (104 citations) and Cancer Research (18 citations). M. Guaraldi has collaborated with scholars based in Italy. Frequent co-authors include Andrea Martoni, F Pannuti, Barbara Melotti, H. Koussis, Adriano Paccagnella, Andrea Bonetti, Maria Grazia Ghi, E Piana, Alessandro Gava and L. Loreggian. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Chemotherapy, European Journal of Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.